Health Canada drug identification number

DIN 02523493 — DEPO-PROVERA 150 MG

DEPO-PROVERA is a suspension of Medroxyprogesterone acetate marketed by PFIZER CANADA ULC. The full Medroxyprogesterone acetate monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02523493
Brand name
DEPO-PROVERA
Strength
150 MG
Dosage form
SUSPENSION
Route
INTRAMUSCULAR
Manufacturer
PFIZER CANADA ULC
Health Canada status
MARKETED
Drug class
Progestin (progestogen) hormone

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Medroxyprogesterone acetate products

DINBrandStrengthFormManufacturerStatus
02277298 AA-MEDROXY 10 MG TABLET AA PHARMA INC MARKETED
02267640 AA-MEDROXY 100 MG TABLET AA PHARMA INC MARKETED
02244726 AA-MEDROXY 2.5 MG TABLET AA PHARMA INC MARKETED
02244727 AA-MEDROXY 5 MG TABLET AA PHARMA INC MARKETED
02221306 TEVA-MEDROXYPROGESTERONE 10 MG TABLET TEVA CANADA LIMITED MARKETED
02221284 TEVA-MEDROXYPROGESTERONE 2.5 MG TABLET TEVA CANADA LIMITED MARKETED
02221292 TEVA-MEDROXYPROGESTERONE 5 MG TABLET TEVA CANADA LIMITED MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.